It is noteworthy that in Crohn's disease, which is proposed to be a Th1/Th17-type autoimmune disease, we found significant reduction in plasma levels of IL-2 (Th1 cytokine) and IL-17 after intake of the AbM-based AndoSan extract by the patients [24]. The gene discussed is IL17A; the disease is autoimmune disease.